Australia markets closed

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
20.95+0.29 (+1.40%)
At close: 04:00PM EDT
20.56 -0.39 (-1.86%)
After hours: 07:59PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
287,530
289,213
618,968
992,584
421,712
Cost of revenue
179,781
184,757
252,067
215,533
89,807
Gross profit
107,749
104,456
366,901
777,051
331,905
Operating expenses
Research development
43,092
41,440
28,910
24,219
11,580
Selling general and administrative
129,059
130,466
149,992
75,171
30,167
Total operating expenses
180,018
179,751
185,399
101,098
41,747
Operating income or loss
-72,269
-75,295
181,502
675,953
290,158
Total other income/expenses net
-
-120,234
-2,975
-
-
Income before tax
-167,209
-174,085
184,025
677,300
291,684
Income tax expense
6,027
1,154
42,102
174,795
72,532
Income from continuing operations
-173,236
-175,239
141,923
506,239
214,310
Net income
-165,947
-167,825
143,403
507,364
214,310
Net income available to common shareholders
-165,947
-167,825
143,403
507,364
214,310
Basic EPS
-2.10
-5.63
4.76
17.25
9.44
Diluted EPS
-2.10
-5.63
4.63
16.38
8.91
Basic average shares
29,747
29,784
30,097
29,408
22,694
Diluted average shares
29,976
29,784
30,964
30,976
24,056